As we have previously discussed, oxidative stress increases during PCa progression and therapy resistance, which provides a cue to the aggressive PCa cells to activate more NRF2 to adapt to higher oxidative stress. This evidence concerns the gene NFE2L2 and posterior cortical atrophy.